In summary, the present study has prompted us to propose the existence of a pathological axis in SLE involving IFNα, BLyS and IL-17, all of which are cytokines with well-known deleterious roles in these patients (Fig. 3). Here, IFNA2 is linked to systemic lupus erythematosus.